Exo Acquires Medo AI to Bring AI-Enabled Ultrasound Imaging to Point-of-Care

July 26, 2022

Exo announced it is acquiring Medo, a Canadian developer of AI technology used for ultrasound imaging. By integrating Medo’s proprietary Sweep AI into Exo’s ultrasound platform, Exo aims to make ultrasound imaging faster and easier for a broader range of caregivers and accelerate adoption of point-of-care ultrasound.

Buyers
Exo
Targets
Medo
Industry
Medical Devices
Location
Canada
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.